Sage View Advisory Group, LLC Abb Vie Inc. Transaction History
Sage View Advisory Group, LLC
- $2.15 Trillion
- Q2 2024
A detailed history of Sage View Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sage View Advisory Group, LLC holds 18,465 shares of ABBV stock, worth $3.59 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
18,465
Previous 14,530
27.08%
Holding current value
$3.59 Million
Previous $2.65 Billion
19.69%
% of portfolio
0.15%
Previous 0.13%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,697Shares Held
1.27BCall Options Held
13MPut Options Held
9.79M-
Vanguard Group Inc Valley Forge, PA171MShares$33.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.1 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.4 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.5 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $344B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...